Breathing Science is Life
For more than 124 years, National Jewish Health has been at the forefront of research and medicine. We integrate the latest scientific discoveries with coordinated care for pulmonary, cardiac, immune and related conditions. National Jewish Health physicians and researchers are at the forefront of a new era in health care that embraces a personalized, preventive approach to medicine.
We understand that each person is unique, and their variations in diet, environment, personal habits and DNA all influence their individual health. That is why two different people are exposed to certain conditions and only one gets sick and why certain treatments may work for one person and not for another. With a focus on personalized medicine, our researchers are looking at environment-gene interaction and making strides in predicting, preventing, treating and tracking many diseases. This proactive approach to medicine means that if you have a disease, or the probability of getting a disease, it may be detected sooner so that you may live longer, healthier and with a better quality of life.
Our research is truly transforming the lives of millions. By using an individual's DNA to predict and prevent disease, to guide the right choice of therapy to limit side effects and bring higher success rates for treatments and to be able to track the effects of these therapies, National Jewish Health is working to improve health care for the future.
Pulmonary, Rheumatology, Allergies & Immunology, Pediatrics, Gastroenterology, and Cardiology
National Jewish Health: Top-ranked care for respiratory, cardiac, immune, and related disorders. Manage appointments & care online. Research & events.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
TIME Startup accelerator & VC, Publishing, Hospitals and Health Care | TIME Startup accelerator & VC, Publishing, Hospitals and Health Care | Other 1 Nov 2022 | | |
Incyte Pharmaceutical, Pharmaceutical Manufacturing | Incyte Pharmaceutical, Pharmaceutical Manufacturing | Other 7 Feb 2022 | |